06:47 AM EDT, 10/20/2025 (MT Newswires) -- Keros Therapeutics ( KROS ) said Monday it launched a cash tender offer to repurchase up to $194.4 million of its common shares at $17.75 each.

The offer is part of the company's previously announced $375 million capital return program.

Keros said it expects to use existing cash and cash equivalents to fund the tender offer, which is scheduled to expire at 5 pm ET Nov. 18.